Xiangya Hospital of Central South University
Changsha, Hunan, 410078, China
NCT Number: NCT02479581
This study evaluates the enhanced recovery after surgery (ERAS) concept over conventional postoperative care in patients with heart valve disease undergoing cardiac surgery with cardiopulmonary bypass. Half of participants will adherence to the ERAS, while the other half will under the conventional postoperative care.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 2
Changsha, Hunan, 410078, China
Enhanced recovery after surgery (ERAS) or fast-track surgery is a perioperative and postoperative care concept initiated in the early 1990s aiming to reduce the length of hospital stays following elective abdominal surgery. The success of ERAS depends highly on multidisciplinary teamwork and patient compliance.
This study intends to compare the Enhanced Recovery After Surgery (ERAS) concept applied to patients with heart valve disease undergoing cardiac surgery with cardiopulmonary bypass under traditional perioperative management of patients, committed to reducing patient's physical and psychological stress by surgical trauma, achieve the purpose of fast recovery, in order to establish an effective perioperative management during cardiopulmonary bypass surgery, improve patients' satisfaction and to accelerate postoperative rehabilitation safely.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intravenous infusion of flucloxacillin sodium 1g an hour before operation
Other names: "yifen®","Flucloxacillin"
Routine preoperative psychological preparation for patients.
Time frame: From pre-surgery to discharge, up to 4 weeks
Time frame: From entering the ICU to roll out, up to 4 weeks
Time frame: From pre-surgery to discharge, up to 4 weeks
Time frame: From pre-surgery to discharge, up to 8 weeks
Time frame: When the patient is discharged
Time frame: From pre-surgery to discharge, up to 4 weeks
Time frame: From the start of drugs to stop them, up to 4 weeks
Time frame: From the end of surgery to the removal of tracheal tube, up to 4 weeks
Time frame: From the end of surgery to the recovery of spontaneous breathing, up to 4 weeks
Time frame: From the end of surgery to first exhaust, up to 2 weeks
Time frame: From the end of surgery to first exhaust, up to 2 weeks
Time frame: baseline and 5 days after operation
1day before and 1-5days after operation
Time frame: baseline and 5 days after operation
1day before and 1-5days after operation
Time frame: baseline and 5 days after operation
1day before and 1-5days after operation
Time frame: baseline and 5 days after operation
1day before and 1-5days after operation
Time frame: baseline and 5 days after operation
1day before and 1-5days after operation
Time frame: baseline and 5 days after operation
1day before and 1-5days after operation
Time frame: baseline and 5 days after operation
1day before and 1-5days after operation
Time frame: Six month
Xiangya Hospital of Central South University
Other
The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS) Applied on Cardiac Surgery With Cardiopulmonary Bypass: a Single Center, Randomized, Controlled Clinical Study
Acronym: ERAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07704086
Aortic Diseases, Arterial Occlusive Diseases
Madrid, Spain
View Trial DetailsNCT05417464
Aortic Valve Disease, Aortic Valve Stenosis
Montpellier, France
View Trial DetailsNCT05666713
Aortic Valve Failure, Body Temperature Changes
San Francisco, California, United States
View Trial DetailsNCT05179278
Cardiovascular Diseases, Heart Diseases
Barcelona, Spain
View Trial Details